Ralph Weichselbaum

University of Chicago Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Anthony Kossiakoff

Professor

University of Chicago

UNITED STATES

View details

Wenyao Zhen

University of Chicago

UNITED STATES

View details

Hasan Zaki

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Wenbin Lin

University of Chicago

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ralph Weichselbaum

Research Interests

Explore related searches

Contact this professor

Articles (15)

Transforming malignant tumors into vulnerable phenotypes via nanoscale coordination polymer mediated cell senescence and photodynamic therapy

YTHDFs as radiotherapy checkpoints in tumor immunity

Tumor aneuploidy as a prognostic and predictive biomarker in immune checkpoint blockade

A universal chimeric-antigen receptor (CAR)- fragment antibody binder (FAB) split system for cancer immunotherapy

Facts and Hopes in Radioimmunotherapy of Oligometastatic Disease

STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition

Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease

Radiotherapy and immunology

Oligometastases: Characterizing the Role of Epigenetic Regulation of Epithelial–Mesenchymal Transition

TLR3 agonist nanoscale coordination polymer synergizes with immune checkpoint blockade for immunotherapy of cancer

The AIM2 and NLRP3 inflammasomes trigger IL-1–mediated antitumor effects during radiation

Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future Focus

(Oligo)metastasis as a Spectrum of Disease

RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy

Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination

Collaborators (4)

Anthony Kossiakoff

Wenyao Zhen

Hasan Zaki

Wenbin Lin

Make your next move.